Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
Wada T, Ishikawa A, Watanabe E, Nakamura Y, Aruga Y, Hasegawa H, Onogi Y, Honda H, Nagai Y, Takatsu K, Ishii Y, Sasahara M, Koya D, Tsuneki H, Sasaoka T.
Wada T, et al. Among authors: ishii y.
J Endocrinol. 2017 Dec;235(3):179-191. doi: 10.1530/JOE-17-0351. Epub 2017 Aug 30.
J Endocrinol. 2017.
PMID: 28855315